tiprankstipranks
Advertisement
Advertisement

SAGE Stock Latest News

Sage Therapeutics Lawsuit: Company Asks Court to Dismiss Investor Securities Claims 
Class ActionSage Therapeutics Lawsuit: Company Asks Court to Dismiss Investor Securities Claims 
20d ago
SAGE
SAGE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
SAGE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
9M ago
SAGE
SAGE Therapeutics Announces Nasdaq Delisting After Merger
PremiumCompany Announcements
SAGE Therapeutics Announces Nasdaq Delisting After Merger
1y ago
8K
SAGE
Supernus completes acquisition of Sage Therapeutics
PremiumThe Fly
Supernus completes acquisition of Sage Therapeutics
1y ago
SAGE
SUPN
Sage Therapeutics reports Q2 EPS (79c), consensus (94c)
PremiumThe Fly
Sage Therapeutics reports Q2 EPS (79c), consensus (94c)
1y ago
SAGE
Supernus announces expiration of HSR waiting period for Sage Therapeutics
PremiumThe FlySupernus announces expiration of HSR waiting period for Sage Therapeutics
1y ago
SAGE
SUPN
Sage Therapeutics downgraded to Sector Perform from Outperform at Scotiabank
Premium
The Fly
Sage Therapeutics downgraded to Sector Perform from Outperform at Scotiabank
1y ago
SAGE
Sage Therapeutics cutting over 330 jobs, Boston Globe reports
Premium
The Fly
Sage Therapeutics cutting over 330 jobs, Boston Globe reports
1y ago
SAGE
SUPN
Sage Therapeutics price target lowered to $8.50 from $11 at JPMorgan
PremiumThe Fly
Sage Therapeutics price target lowered to $8.50 from $11 at JPMorgan
1y ago
SAGE
Avidity, BridgeBio, Coty, SAGE, Alkermes: Trending by Analysts
PremiumWeekend Updates
Avidity, BridgeBio, Coty, SAGE, Alkermes: Trending by Analysts
1y ago
RNA
ALKS
Sage Therapeutics price target raised to $9 from $7 at Baird
PremiumThe Fly
Sage Therapeutics price target raised to $9 from $7 at Baird
1y ago
SAGE
H.C. Wainwright sees potential competition for Sage from Biogen
PremiumThe Fly
H.C. Wainwright sees potential competition for Sage from Biogen
1y ago
BIIB
SAGE
Sage Therapeutics price target raised to $9 from $8 at Truist
PremiumThe FlySage Therapeutics price target raised to $9 from $8 at Truist
1y ago
SAGE
SUPN
Hold Rating on SAGE Therapeutics Amid Uncertainty and Acquisition Developments
Premium
Ratings
Hold Rating on SAGE Therapeutics Amid Uncertainty and Acquisition Developments
1y ago
SAGE
Sage Therapeutics price target raised to $8.50 from $8 at Canaccord
Premium
The Fly
Sage Therapeutics price target raised to $8.50 from $8 at Canaccord
1y ago
BIIB
SAGE
Sage Therapeutics price target raised to $8.50 from $8 at Canaccord
PremiumThe Fly
Sage Therapeutics price target raised to $8.50 from $8 at Canaccord
1y ago
BIIB
SAGE
Hold Rating on SAGE Therapeutics Amid Acquisition Offer and CVR Uncertainties
PremiumRatings
Hold Rating on SAGE Therapeutics Amid Acquisition Offer and CVR Uncertainties
1y ago
SAGE
Sage Therapeutics moved to No Rating at BofA
PremiumThe Fly
Sage Therapeutics moved to No Rating at BofA
1y ago
SAGE
Sage Therapeutics downgraded to Neutral from Overweight at Piper Sandler
PremiumThe Fly
Sage Therapeutics downgraded to Neutral from Overweight at Piper Sandler
1y ago
SAGE
Sarepta suspends Elevidys shipments, Supernus acquires Sage: Morning Buzz
PremiumThe FlySarepta suspends Elevidys shipments, Supernus acquires Sage: Morning Buzz
1y ago
BA
BMY
Morning Movers: Sage Therapeutics surges after deal to be acquired by Supernus
Premium
The Fly
Morning Movers: Sage Therapeutics surges after deal to be acquired by Supernus
1y ago
X
AMZN
Video: Sarepta, Hinge Health among major pre-market movers
Premium
The Fly
Video: Sarepta, Hinge Health among major pre-market movers
1y ago
HNGE
INCY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >